IBB News and Press, iShares Biotechnology ETF From 06/03/23

2023-06-03 20:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-05-25 11:22:56 ET Summary I have previously discussed the factors that led to the significant decline in biopharmaceutical stocks in 2021, including companies going public at too early a stage and valuations being excessive. The dramatic correction seems to have bottomed in J...

2023-05-25 05:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-05-23 09:50:41 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech stocks have gotten caught up in the broader technology sector sell-off. The benchmark iShares Biotechnology ETF (NYSEARCA: IBB ) has fallen from a peak of ...

2023-05-23 08:35:26 ET Summary Undervalued: the stock is currently in the oversold territory after some investors over-reacted and sold after the Phase 2 BEXO trial, we like the FVC slow down and clean safety data. Promising Upcoming Trials: The mid-2023 Phase 2b BEACON-IPF trial ...

2023-05-18 03:36:47 ET Summary Several ETFs exist offering investors concentrated biotech exposure that varies in stock selection and weighting schemes. While all of the choices exhibit 90%+ exposure to biotech stocks, only XBI is a true pure-play at nearly 100%. The low relat...

2023-05-17 02:56:26 ET Summary Key update: as we predicted, FDA approval for LUMRYZ, a unique once-at-bedtime narcolepsy treatment. Orphan Drug Exclusivity is granted until May 1, 2030, offering attractive patent protection. Launch expected in June 2023, with a fast sales ramp ant...

2023-05-17 00:15:00 ET Summary One of the most promising applications of AI in drug discovery is in the identification of new drug targets (AI can be used to discover new drugs). The ability to analyze large amounts of molecular and genomic data quickly and efficiently is somethin...

2023-05-17 00:00:00 ET Summary Markets are being shaped by disparate trends from falling energy prices to rising interest rates. During first-quarter earnings season, company reports indicated that these crosscurrents are intensifying business challenges—and making it harde...

2023-05-16 19:09:57 ET Summary Many US-listed biotech companies are likely to trade cheaply relative to their prospects as a result of concerns about the stability of the US banking system and the risk of a recession. I believe biotech investors should consider a "Buy" rating on A...